CRA approach
- Leveraged prior CRA working knowledge and extensive primary and secondary research
- Whitepaper focused on the following elements:
- Gene therapy landscape and future pipeline
- Overcoming pricing challenges via value demonstration
- Health system/payer/patient affordability issues
- Triggers for systemic change
Client impact
- Business development, pricing, and commercialization decisions based on adaptive frameworks and heuristics